Pain relief after robotic sleeve gastrectomy: Zynrelef vs Exparel
Treatments studied
Part of Pain clinical trials.
This trial compares two long-acting pain medicines, Zynrelef and Exparel, to see which works better for pain control after robotic sleeve gastrectomy. The goal is to improve recovery and reduce the need for stronger painkillers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are scheduled for robotic sleeve gastrectomy with Dr. Goyal.
- You can give written consent and follow the study schedule.
- You are not taking daily narcotics now and have not abused drugs in the past year.
- You are not pregnant, breastfeeding, or in prison.
- You have no allergies to the medicines used in the study, including certain pain relievers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is comparing different ways to manage pain after a specific type of lower back fusion surgery called TLIF. The goal is to find the best pain control plan to make recovery more comfortable.
This trial tests two different pain-relief medicines (R.E.C.K. and Exparel) given during robotic kidney surgery. It aims to find which works better to control pain after the operation.
This trial compares a new long-acting painkiller (Zynrelef) to a standard nerve block for pain after knee replacement surgery. It aims to find which method provides better pain relief with fewer side effects.
This study compares two different pain-relief injection techniques (BDE and Exparel) given during abdominal wall reconstruction surgery to see which works better at reducing pain and opioid use after surgery. You would receive one of these injections as part of your anesthesia care.
This study tests if a long-lasting numbing medicine called Exparel, given by the surgeon during knee replacement, helps control pain after surgery. It is for people having their first total knee replacement on one knee due to arthritis.
This trial tests whether a long-lasting numbing shot (liposomal bupivacaine) works better than a regular numbing shot (plain bupivacaine) for pain after minimally invasive chest surgery. It may help you have less post-surgery pain and potentially use less pain medication.
Hear when a new Post Operative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.